Correction to Lancet Oncol 2024; 25: 1176–87

Abstract

Vera P, Thureau S, Le Tinier F, et al. Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial. Lancet Oncol 2024; 25: 1176–87—In this Article, Pierre Boissellier should have been spelled Pierre Boisselier. This correction has been made to the online version as of Oct 25, 2024.